| ARCHETYPE ID | openEHR-EHR-EVALUATION.drugallergy.v1 |
|---|---|
| Concept | Drug allergy |
| Description | Details of an an allergy or other adverse reaction to a drug or other medicinal substance. |
| Use | This archetype is very closely aligned to the CfH GP2GP Drug allergy archetype and should be used to record allergies, intolerances and adverse reactions to drugs and other medicinal substances. It is designed primarily for use with in a UK primary care context but may be suitable for use within secondary care, particularly where the prime requirement is to record propensity to drug allergy for decision support purposes. |
| Misuse | This archetype should not be used to record adverse reactions or allergies to non-medicinal substances such as foodstuffs, pollens or animals. |
| Purpose | To record details of a known or suspected allergy or other adverse reaction, intolerance to a drug or medicinal substance, drug group or trade family group of drugs. |
| References | NHS Scotland SCI-XML schema http://www.sci.scot.nhs.uk/products/gateway/gate_down_xml.htm DoH, UK NHS Message Implementation Guidance, http://www.uktcregistration.nss.cfh.nhs.uk/trud3/user/guest/group/0/pack/23;jsessionid=D52317DAD88F60096DFF3113BA604F1A |
| Copyright | © openEHR Foundation |
| Authors | Author name: Ian McNicoll Organisation: Ocean Informatics, UK Email: ian.mcnicoll@oceaninformatics.com Date originally authored: 2012-09-12 |
| Other Details Language | Author name: Ian McNicoll Organisation: Ocean Informatics, UK Email: ian.mcnicoll@oceaninformatics.com Date originally authored: 2012-09-12 |
| Other Details (Language Independent) |
|
| Keywords | allergy, adverse, intolerance |
| Lifecycle | Initial |
| Language used | en |
| Citeable Identifier | 1013.1.955 |
| protocol | |
| Record provenance | Record provenance: Details of the provenance of the record e.g. source, name and role of author, care setting. Include: openEHR-EHR-CLUSTER.record_ |
| data | |
| Causative agent | Causative agent: Details of the agent or medicinal substance believed to be the cause of the adverse reaction or allergy. For GP2GP V2 use, there are 4 permissible ways to express a Causative agent: Drug Group (SNOMED-CT), dm+d VMP/AMP (dm+d), Ingredient (SNOMED-CT), TradeFamily/TradeFamilyGroup (SNOMED-CT). It is MANDATORY that one and only one of these must always be selected. Optionally, in addition a SNOMED AllergyCode may be sent as a mapping, but can never be sent on its own. For legacy use other codes are permissible such as FDB Agent codes, EMIS Drug codes and READ codes. Constraint: CausativeAgent [A causative agent term from one of the approved terminology subsets.] Constraint bindings:
|
| Reaction | Reaction: An optional pre-coodinated unqualified SNOMED-CT code for the nature of the reaction produced by the drug allergy. Constraint: Clinical Finding [Any SNOMED-CT term in the Clinical Finding hierarchy.] Constraint binding:
|
| Certainty | Certainty: The certainty with which the reaction is deemed to be be due to allergy to the agent. This item has a Translation Set= Read Code (V2 or CTV3) and Snomed Code to ensure forwards and backwards compatability.
|
| Severity | Severity: The severity of the reaction. This item has a Translation Set = Read Code (V2 or CTV3) and Snomed Code to ensure forwards and backwards compatability.
|
| Date of onset | Date of onset: The date of onset of the reaction. From Welsh IHR model |
| Comment | Comment: Any additional comment about the allergy. From Welsh IHR model |
| Other contributors | Leo Fogarty, GP2GP project, NHS England John Williams, GP2GP project, NHS England |
| Translators |